Veniti (Saint Louis, MO) a development-stage medical device company focused on iliac vein outflow obstruction, closed a $13.5M Series A financing. Participants include Baird Venture Partners and H&Q Healthcare Investors.

AssureRx Health (Mason, OH) a commercial-stage personalized medicine company focused on a pharmacogenetic platform for the determination of drug at selection and dosage, closed a $11M Series B financing. Participants include Claremont Creek Ventures, Sequoia Capital and Allos Ventures.

BridgePoint Medical (Minneapolis, MN) a clinical-stage medical device company focused on interventional cardiology for access to and treatment of chronic total occlusions, closed a $9.1M Series C financing. Participants include New Enterprise Associates, Polaris Venture Partners and Foundation Medical Partners.

NxThera (St. Paul, MN) a development-stage medical device company focused on endourology conditions, closed a $12.6M million in Series B financing. Participants include American Medical Systems, Arboretum Ventures, Aberdare Ventures and GDN Holdings.

NanoInk (Skokie, IL) a commercial-stage a protein analysis, biomaterial manufacturing and biodiscovery assay kit developer, closed a$65M Series E financing. Participants include Lurie Investment Fund.

Virtual Incision (Lincoln, NE) a development stage medical device company focused on remote operated in vivo robotic surgical laparoscopic tools and cameras, closed a $2M Series A financing. Participants include PrairieGold Venture Partners and Bluestem Capital.

And cue the confetti cannon as we celebrate the 1,000th OnBioVC.com post!

AxioMed Spine (Cleveland, OH) a clinical-stage medical device company focused on lumbar disc replacement, closed a $15M Series D financing. Participants have included Thomas, McNerney & Partners, CID Equity Partners, Early Stage Partners, Investor Growth Capital, MB Venture Partners, Primus Capital Funds and Reservoir [...]

SuperDimesnion (Minneapolis, MN) a commercial-stage medical device company focused on minimally invasive distal lung disease treatments, closed a $9.8M Series B financing. Participants include Dan Sullivan Investments, Medica Venture Partners, OrbiMed, Oxford Biosciences Partners and Pitango Venture Capital.

Accuri Cytometers (Ann Arbor, MI) a commercial-stage device company focused on flow cytometery solutions for the R&D market, closed a $6M Series E financing. Participants include Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and InvestMichigan.

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Swift Biosciences (Ann Arbor, MI) a development-stage company focused on molecular biology reagents for R&D and diagnostics, closed a $3M Series A financing. Participants include DFJ Mercury.

Coskata (Warrenville, IL) a development-stage bacterial fermentation biofuels company closed a $23.7M Series D financing. Participants include Total, Blackstone Group, Advanced Technology Ventures, Globespan Capital Partners, General Motors, GreatPoint Ventures and Khosla Ventures.

Delphinus Medical Technologies (Detroit, MI) a development-stage medical device company focused on tomographic ultrasound imaging for breast cancer, closed an $8M Series A financing. Participants include Arboretum Ventures, Beringea and North Coast Technology Investors.